Status:
COMPLETED
Probiotics for Chalaziosis Treatment in Children
Lead Sponsor:
University of Molise
Conditions:
Chalazion
Eligibility:
All Genders
3-14 years
Phase:
NA
Brief Summary
There is growing evidence encouraging the use of probiotics in many conditions in children. The aim of the investigator's study is to define the possible beneficial impact of probiotics on paediatric ...
Detailed Description
Prospective comparative pilot study on 26 children suffering from chalaziosis. They will be randomly divided in two groups. One group will receive conservative treatment and the other one will receive...
Eligibility Criteria
Inclusion
- paediatric patients
- presence of one or more eyelid mass lesions (history of rapid onset of painful inflamed mass that had reached a stationary size for more than 2 months)
Exclusion
- eyelid infection
- chalazion duration \< 1 month
- nonpalpable chalazion
- suspicion of malignancy
Key Trial Info
Start Date :
February 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 29 2020
Estimated Enrollment :
26 Patients enrolled
Trial Details
Trial ID
NCT04322500
Start Date
February 1 2019
End Date
February 29 2020
Last Update
May 5 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Molise
Campobasso, Italy